SPDR S&P Biotech (ETF) (AMEX:XBI)

CAPS Rating: 3 out of 5

Exchange traded funds

Recs

3
Player Avatar zzlangerhans (99.67) Submitted: 3/2/2009 1:47:53 PM : Outperform Start Price: $44.05 XBI Score: -1.98

Is this the right time to call a bottom in the latest biotech plunge? It's hard to know, but I am the kind of guy that enjoys a nice bottom. So here goes ...

Featured Broker Partners


Advertisement